Monkeypox vaccines, including second doses, available at upcoming Baton Rouge vaccination events
COVID-19 vaccines, including the updated COVID-19 bivalent booster which is authorized for people ages 12 and up, will be available, too.
An official website of the State of Louisiana.
COVID-19 vaccines, including the updated COVID-19 bivalent booster which is authorized for people ages 12 and up, will be available, too.
COVID-19 vaccine and updated COVID-19 bivalent boosters are also available
The Louisiana Department of Health, in partnership with the New Orleans Health Department, will offer monkeypox vaccines, including second doses, at events starting next week.
The Louisiana Department of Health Office of Public Health Region 9 (Northshore) has monkeypox vaccines available at its parish health units (PHUs).
These updated boosters offer continued protection against the original strain, while also offering better protection against the BA.4 and BA.5 Omicron variants, which represent over 90% of currently circulating virus.
The Louisiana Department of Health today announced it is now able to expand eligibility for JYNNEOS, the monkeypox vaccine, thanks to increased supply.
The Health Hub will be located at the main North Rampart Street entrance of Louis Armstrong Park (801 N. Rampart St.), conveniently located near the French Quarter where many Southern Decadence events and activities will occur.
The Louisiana Department of Health (LDH) Office of Public Health (OPH) Region 4 (Acadiana) has monkeypox vaccines available at its parish health units.
The Louisiana Department of Health, the East Baton Rouge Parish Mayor's Office and other community partners are hosting a series of monkeypox and COVID-19 vaccination events in Baton Rouge, starting Saturday, August 27.
Among the cases included in today's demographic analysis, approximately 95% have occurred in males.
Dr. Courtney N. Phillips, Secretary of the Louisiana Department of Health, says preventing infectious diseases is one key area of improvement for the health of Louisiana residents.
The U..S Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) allowing healthcare providers to use an alternative dosing regimen of the JYNNEOS vaccine for individuals 18 years of age and older determined to be at high risk of monkeypox infection. This will increase the total number of doses available for use by up to five-fold.